These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 7577661

  • 1. The efficacy of tamoxifen as an antiproliferative agent in vitro for benign and malignant pediatric glial tumors.
    Pollack IF, Kawecki S.
    Pediatr Neurosurg; 1995; 22(6):281-8. PubMed ID: 7577661
    [Abstract] [Full Text] [Related]

  • 2. Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen.
    Baltuch GH, Couldwell WT, Villemure JG, Yong VW.
    Neurosurgery; 1993 Sep; 33(3):495-501; discussion 501. PubMed ID: 8413883
    [Abstract] [Full Text] [Related]

  • 3. Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro.
    Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT.
    Cancer Res; 1990 Nov 15; 50(22):7134-8. PubMed ID: 2224848
    [Abstract] [Full Text] [Related]

  • 4. The effect of calphostin C, a potent photodependent protein kinase C inhibitor, on the proliferation of glioma cells in vitro.
    Pollack IF, Kawecki S.
    J Neurooncol; 1997 Feb 15; 31(3):255-66. PubMed ID: 9049854
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tamoxifen modulation of carboplatin cytotoxicity in a human U-138 glioma cell line.
    Mastronardi L, Farah JO, Puzzilli F, Ruggeri A.
    Clin Neurol Neurosurg; 1998 Jun 15; 100(2):89-93. PubMed ID: 9746294
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of radiosensitivity by tamoxifen in C6 glioma cells.
    Zhang W, Yamada H, Sakai N, Niikawa S, Nozawa Y.
    Neurosurgery; 1992 Oct 15; 31(4):725-9; discussion 729-30. PubMed ID: 1407459
    [Abstract] [Full Text] [Related]

  • 8. Paradoxical elevation of Ki-67 labeling with protein kinase inhibition in malignant gliomas.
    Couldwell WT, Weiss MH, Law RE, Hinton DR.
    J Neurosurg; 1995 Mar 15; 82(3):461-8. PubMed ID: 7861225
    [Abstract] [Full Text] [Related]

  • 9. Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53.
    Weller M, Trepel M, Grimmel C, Schabet M, Bremen D, Krajewski S, Reed JC.
    Neurol Res; 1997 Oct 15; 19(5):459-70. PubMed ID: 9329022
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of Ras and related G-proteins as a therapeutic strategy for blocking malignant glioma growth.
    Bredel M, Pollack IF, Freund JM, Hamilton AD, Sebti SM.
    Neurosurgery; 1998 Jul 15; 43(1):124-31; discussion 131-2. PubMed ID: 9657198
    [Abstract] [Full Text] [Related]

  • 11. Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells.
    Jane EP, Premkumar DR, Pollack IF.
    J Pharmacol Exp Ther; 2006 Dec 15; 319(3):1070-80. PubMed ID: 16959960
    [Abstract] [Full Text] [Related]

  • 12. Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways.
    Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT.
    J Neurosurg; 1990 Jul 15; 73(1):98-105. PubMed ID: 2161913
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma.
    Chen TC, Su S, Fry D, Liebes L.
    Cancer; 2003 May 01; 97(9 Suppl):2363-73. PubMed ID: 12712458
    [Abstract] [Full Text] [Related]

  • 14. High-dose tamoxifen in treatment of brain tumors: interaction with antiepileptic drugs.
    Rabinowicz AL, Hinton DR, Dyck P, Couldwell WT.
    Epilepsia; 1995 May 01; 36(5):513-5. PubMed ID: 7614929
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the relative chemosensitivity of human gliomas to tamoxifen and n-desmethyltamoxifen in vitro.
    Vertosick FT, Selker RG, Randall MS, Kristofik MP, Rehn T.
    J Neurooncol; 1994 May 01; 19(2):97-103. PubMed ID: 7964994
    [Abstract] [Full Text] [Related]

  • 16. Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C.
    Couldwell WT, Antel JP, Yong VW.
    Neurosurgery; 1992 Oct 01; 31(4):717-24; discussion 724. PubMed ID: 1407458
    [Abstract] [Full Text] [Related]

  • 17. Disparity in expression of protein kinase C alpha in human glioma versus glioma-derived primary cell lines: therapeutic implications.
    Zellner A, Fetell MR, Bruce JN, De Vivo DC, O'Driscoll KR.
    Clin Cancer Res; 1998 Jul 01; 4(7):1797-802. PubMed ID: 9676858
    [Abstract] [Full Text] [Related]

  • 18. Malignant glioma sensitivity to radiotherapy, high-dose tamoxifen, and hypericin: corroborating clinical response in vitro: case report.
    Zhang W, Hinton DR, Surnock AA, Couldwell WT.
    Neurosurgery; 1996 Mar 01; 38(3):587-90; discussion 590-1. PubMed ID: 8837815
    [Abstract] [Full Text] [Related]

  • 19. Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitor.
    Pollack IF, Kawecki S, Lazo JS.
    J Neurosurg; 1996 Jun 01; 84(6):1024-32. PubMed ID: 8847567
    [Abstract] [Full Text] [Related]

  • 20. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases.
    Pollack IF, Claassen D, al-Shboul Q, Janosky JE, Deutsch M.
    J Neurosurg; 1995 Apr 01; 82(4):536-47. PubMed ID: 7897512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.